News and Trends 8 Mar 2023
The challenges of tackling dementia in women
Dr Andrea Pfeifer, chief executive officer of AC Immune SA, talks to Labiotech about dementia research, and how dementia affects…
Parkinson’s
- Latest Posts
More News! 2 Mar 2023
Could new dementia treatment come from intestinal bacteria discovery?
Dementia with Lewy bodies (DLB), one of the most common forms of dementia, has no cure. Previous studies suggested that…
News and Trends 12 Jan 2023
JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases
The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has issued a call for multinational research on large scale…
News and Trends 20 Dec 2022
Watch: IRLAB CEO Richard Godfrey
IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam…
ADVERTISEMENT
News and Trends 15 Nov 2022
BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat pathologies such as amyotrophic lateral…
News and Trends 10 Nov 2022
Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS
NRG Therapeutics, Ltd. has closed a £16 million ($18.2 million) series A financing. The funding was led by Omega Funds…
News and Trends 11 Oct 2022
Muna Therapeutics gets $4.9M grant for Parkinson’s disease research
Muna Therapeutics has been awarded a $4.9 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The…
News and Trends 15 Sep 2022
Neuron23 and QIAGEN to collaborate on diagnostic for novel Parkinson’s drug
Neuron23 Inc. and QIAGEN are to collaborate to develop a companion diagnostic for Neuron23's LRRK2 inhibitor for Parkinson's disease. Under…
News and Trends 14 Sep 2022
Collaboration to explore gene therapy products for neurodegenerative disorders
Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop gene therapy proteins targeting protein…
News and Trends 6 Sep 2022
IRLAB’s partner Ipsen starts mesdopetam clinical studies
IRLAB Therapeutics AB, a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most troublesome symptoms of Parkinson’s disease,…
ADVERTISEMENT
News and Trends 23 Aug 2022
Parkinson’s Foundation and Parkinson’s UK partner to drive drug development
The Parkinson's Foundation and Parkinson's UK, which funds research and provides support for people with Parkinson's disease (PD), have announced…
News and Trends 30 Jun 2022
NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule disease-modifying medicines for the treatment…
News and Trends 10 Jun 2022
Expansion into Europe for BlueRock Therapeutics
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has established a new site for…
News and Trends 31 May 2022
Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments
UK neuroscience company NRG Therapeutics Ltd has received a Biomedical Catalyst (BMC) award to fund preclinical development of its small…
Sponsored by WuXi AppTec
22 Sep 2021Discovering New Therapeutic Targets for Alzheimer’s Disease
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is difficult, time-consuming, and expensive, with…
News and Trends 12 Aug 2021
European Biotechs Fire up Deals to Develop Parkinson’s Treatments
Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or license treatments for Parkinson's disease.…
ADVERTISEMENT
In Depth 22 Mar 2021
Can Immunotherapy Offer Hope for Parkinson’s Sufferers?
Despite decades of research, effective treatments for Parkinson’s disease are proving elusive. Could immunotherapy finally provide a solution? More than…
News and Trends 9 Jun 2020
French Manufacturing Plant Launches to Make Cell Therapy Cheap and Scalable
The Bordeaux-based company Treefrog Therapeutics has opened an industrial demonstration plant with the aim of producing cell therapies 10 times…
More News! 27 Jun 2019
German Biotech Will Target Parkinsonian Disorders with €12M Series A
Modag has developed a candidate drug targeting the neurodegenerative disease multiple system atrophy, which it plans to take to the…
News and Trends 13 May 2019
Cell Encapsulation Biotech Raises €7M to Target Cell Therapy Bottlenecks
The French company Treefrog Therapeutics has raised over €7M in Series A investment to develop its encapsulation technology to improve…